Acetyl-CoA: An interplay between metabolism and epigenetics in cancer
Open accessThe DOI matches its Crossref record; 136 of the 138 references it cites were found in a registry or an index.
Abstract
Due to its high mortality and severe economic burden, cancer has become one of the most difficult medical problems to solve today. As a key node in metabolism and the main producer of energy, acetyl-coenzyme A (acetyl-CoA) plays an important role in the invasion and migration of cancer. In this review, we discuss metabolic pathways involving acetyl-CoA, the targeted therapy of cancer through acetyl-CoA metabolic pathways and the roles of epigenetic modifications in cancer. In particular, we emphasize that the metabolic pathway of acetyl-CoA exerts a great impact in cancer; this process is very different from normal cells due to the “Warburg effect”. The concentration of acetyl-CoA is increased in the mitochondria of cancer cells to provide ATP for survival, hindering the growth of normal cells. Therefore, it may be possible to explore new feasible and more effective treatments through the acetyl-CoA metabolic pathway. In addition, a growing number of studies have shown that abnormal epigenetic modifications have been shown to play contributing roles in cancer formation and development. In most cancers, acetyl-CoA mediated acetylation promotes the growth of cancer cells. Thus, acetylation biomarkers can also be detected and serve as potential cancer prediction and prognostic markers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“acetylation relies on acetyl-CoA (Box 1, Figure I); a key node in various metabolic pathways which are commonly dysregulated in cancer [1–3].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of chromatin by histone modifications
Bannister, A. J., & Kouzarides, T. (2011) · Cell Research · doi:10.1038/cr.2011.22 · Cited by 6,012 · cited 1×
“Therefore, acetylation can be considered an active labelling method (Bannister and Kouzarides, 2011).”
BackgroundThe Warburg Effect: How Does it Benefit Cancer Cells?
Liberti, M. V., & Locasale, J. W. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.12.001 · Cited by 5,150 · cited 1×
“In contrast to normal tissue, the Warburg effect in cancer cells leads to the production of large amounts of lactic acid, resulting in glucose deprivation even when there is sufficient oxygen (Liberti and Locasale, 2016).”
BackgroundFatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941 · cited 1×
“In addition to the Warburg effect, the most important metabolic feature of cancer is altered de novo lipid synthesis (Menendez and Lupu, 2007).”
BackgroundATP-citrate lyase links cellular metabolism to histone acetylation
Wellen, K. E., Hatzivassiliou, G., Sachdeva, U. M., Bui, T. V., Cross, J. R., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1164097 · Cited by 2,298 · cited 2×
“Previous research has shown that an increase in the acetyl-CoA synthesis rate promotes posttranslational histone acetylation at specific gene sites and accelerates cell division (Wellen et al., 2009; Shi and Tu, 2013).”
BackgroundReductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
Metallo, C. M., Gameiro, P. A., Bell, E. L., Mattaini, K. R., Yang, J., Hiller, K., Jewell, C. M., Johnson, Z. R., Irvine, D. J., Guarente, L., et al. (2012) · Nature · doi:10.1038/nature10602 · Cited by 1,791 · cited 1×
“In cancer, in which hypoxic conditions are caused by the compression of proliferating cancer cells, acetate and glutamine are the main sources of acetyl-CoA (Metallo et al., 2012; Kamphorst et al., 2014) (Figure 2).”
BackgroundBonnet, S., Archer, S. L., Allalunis-Turner, J., Haromy, A., Beaulieu, C., Thompson, R., Lee, C. T., Lopaschuk, G. D., Puttagunta, L., Bonnet, S., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.10.020 · Cited by 1,530
Mattiuzzi, C., & Lippi, G. (2019) · Journal of Epidemiology and Global Health · doi:10.2991/jegh.k.191008.001 · Cited by 1,491
Regulation of hepatic fatty acid oxidation and ketone body production
McGarry, J. D., & Foster, D. W. (1980) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.49.070180.002143 · Cited by 1,460
Acidity Generated by the Tumor Microenvironment Drives Local Invasion
Estrella, V., Chen, T., Lloyd, M., Wojtkowiak, J., Cornnell, H. H., Ibrahim-Hashim, A., Bailey, K., Balagurunathan, Y., Rothberg, J. M., Sloane, B. F., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2796 · Cited by 1,397
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
Cheng, Y., He, C., Wang, M., Ma, X., Mo, F., Yang, S., Han, J., & Wei, X. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0095-0 · Cited by 1,097 · cited 1×
“In fact, epigenetic targeted therapy has shown viable therapeutic potential in cancer treatment and is not limited to the regulation of histone acetylation related enzymes, but also the development of new drugs for DNA methylation and histone methylation related enzymes (Cheng et al., 2019).”
Background
Cited by
Reprogrammed immuno-metabolic environment of cancer: the driving force of ferroptosis resistance
Bhowmick, S., Banerjee, S., Shridhar, V., & Mondal, S. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02337-3 · Cited by 51
Panda, S. S., Sahoo, R. K., Patra, S. K., Biswal, S., & Biswal, B. K. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.104061 · Cited by 40
Tomar, M. S., Kumar, A., & Shrivastava, A. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.149382 · Cited by 22
Acetylation: a new target for protein degradation in cancer
Crawford, C. E. W., & Burslem, G. M. (2025) · Trends in Cancer · doi:10.1016/j.trecan.2025.01.013 · Cited by 20
Chaperone-mediated autophagy as a modulator of aging and longevity
Endicott, S. J. (2024) · Frontiers in Aging · doi:10.3389/fragi.2024.1509400 · Cited by 19
Metadata
- Authors
- Hao, Y., Yi, Q., XiaoWu, X., WeiBo, C., GuangChen, Z., & XueMin, C.
- Affiliations
- The First People's Hospital of Changzhou (CN)
- Corresponding author
- XueMin, Chen
- Venue
- Frontiers in Molecular Medicine
- Publisher
- Frontiers Media SA
- Published
- 2022-11-16
- Volume
- 2
- Pages
- 1044585-1044585
- ISSN
- 2674-0095 (ISSN-L)
- PMC
- PMC11285595
- OpenAlex
- W4309312241
- Cited by
- 26
- References
- 138
- Citations by year
- 2026: 12 · 2025: 6 · 2024: 7 · 2023: 1
- FWCI
- 0.42
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Molecular Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- acetyl-CoA, cancer metabolism, epigenetic modifications, Warburg effect, mitochondrial metabolism, acetylation, cancer therapy, prognostic factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Acetyl-CoA: An interplay between metabolism and epigenetics in cancer. https://app.cochat.ai/papers/10.3389/fmmed.2022.1044585
- The paper
- Hao, Y., Yi, Q., XiaoWu, X., WeiBo, C., GuangChen, Z., & XueMin, C. (2022). Acetyl-CoA: An interplay between metabolism and epigenetics in cancer. Frontiers in Molecular Medicine. https://doi.org/10.3389/fmmed.2022.1044585
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.